[1]
Chen, N., Li, G., Li, H., Xiang, X., Guo, G., Ma, Q. and Zhang, Y. 2020. Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer. Cellular and Molecular Biology. 66, 5 (Jul. 2020), 208–213. DOI:https://doi.org/10.14715/cmb/2020.66.5.35.